Dhawaan, sida laga soo xigtay saadaasha waxqabadka sanadlaha ah ee Well Lead Medical ee 2025, xisaabinta hordhaca ah ee shirkaddu ay samaysay waaxda maaliyaddu waxay ku qiyaastay in faa'iidada saafiga ah ee ay yeelan karaan milkiilayaasha shirkadda waalidka ah ee 2025 ay u dhaxayn doonto RMB 75 milyan iyo 95 milyan. Tani waxay ka dhigan tahay hoos u dhac RMB 144.39 milyan ilaa RMB 124.39 milyan marka la barbar dhigo isla muddadaas sannadkii hore, taasoo ah hoos u dhac sanadle ah oo ah 66% ilaa 57%.
Faa'iidada saafiga ah ee la qiyaasay ee ay yeelan karaan milkiilayaasha shirkadda waalidka ka dib markii laga jaray faa'iidada iyo khasaaraha aan soo noqnoqon ee 2025 waa inta u dhaxaysa RMB 65 milyan iyo 85 milyan. Tani waxay ka dhigan tahay hoos u dhac RMB 145.02 milyan ilaa RMB 125.02 milyan marka la barbar dhigo isla muddadaas sannadkii hore, taasoo ah hoos u dhac sanadle ah oo ah 69% ilaa 60%.
Marka laga hadlayo sababaha hoos u dhaca weyn ee faa'iidada, shirkaddu waxay sheegtay in waxqabadka hawlgalka ee shirkadda hoos timaada ee ay si buuxda u leedahay, Jiangxi Langhe Medical Instrument Co., Ltd. (oo hadda loogu yeero "Langhe Medical"), uu si weyn u xumaaday sababtoo ah hoos u dhaca kobaca baahida suuqa alaabta iyo tartanka warshadaha ee xooggan.
Shirkaddu waxay heshay 100% saami qaybsiga Langhe Medical sannadkii 2018, taasoo keentay in la helo 269.367 milyan oo RMB ah. Iyada oo lagu saleynayo xaaladda hadda ee Langhe Medical iyo falanqaynta mustaqbalka ganacsigeeda, maamulka shirkaddu wuxuu si hordhac ah u qiimeeyaa in ay jiraan tilmaamo muujinaya hoos u dhac ku yimid niyad wanaagga ka dhashay iibsigan.
Si si cad oo caddaalad ah loogu muujiyo xaaladda maaliyadeed ee shirkadda iyo qiimaha hantida, iyadoo la raacayo siyaasadaha xisaabinta ee khuseeya sida "Heerarka Xisaabaadka ee Shirkadaha Ganacsiga Lambarka 8 - Naafonimada Hantida" iyo mabda'a taxaddarka, shirkaddu waxay filaysaa inay aqoonsato khasaare naafonimo oo ku yimaada wanaagga oo qiyaastii ah RMB 147 milyan sannadka 2025. Lacagta naafonimada ugu dambeysa waxaa go'aamin doona ka dib qiimeynta iyo hubinta hay'adaha qiimaynta iyo hanti-dhawrka ee ay shirkaddu ku hawlan tahay.
Xaqiiqdii, qeybtii hore ee 2025, waxqabadka Well Lead Medical ayaa wali sii kordhayay. Sida laga soo xigtay shirkadda, inkastoo xaalado juqraafiyeed iyo dhaqaale oo aad u daran gudaha iyo dibaddaba H1 2025, shirkaddu waxay si dhow diiradda u saartay istaraatiijiyaddeeda guud ee horumarinta, hababka suuqa ku salaysan, horumarinta alaabada cusub ee la xoojiyay, suuqyada si firfircoon loo ballaariyay, iyo iibinta gudaha iyo dibadda ee isku dheelitiran, iyadoo la gaaray kobac waxqabad oo deggan. H1 2025, shirkaddu waxay gaartay wadarta dakhliga hawlgalka oo ah RMB 745 milyan, koror sanadle ah oo ah 10.19%; faa'iidada saafiga ah ee ay leeyihiin saamileyda shirkadda waalidka ah waxay ahayd RMB 121 milyan, kor u kacday 14.17% sanadba sanadka ka dambeeya; faa'iidada saafiga ah ee ay leeyihiin saamileyda shirkadda waalidka ah ka dib markii laga jaray faa'iidooyinka iyo khasaaraha aan soo noqnoqonayn waxay ahayd RMB 118 milyan, koror dhan 16.42% sanadba sanadka ka dambeeya.
Waxaa xusid mudan in dhawaan, Ururka Qaranka ee Iibka Dhexe ee Isticmaalka Caafimaadka ee Qiimaha Sare leh uu soo saaray natiijooyinka xulashada dufcaddii lixaad ee iibka ku salaysan mugga qaranka ee loogu talagalay alaabta qiimaha sare leh. Qaybta faragelinta kaadi-mareenka, Well Lead Medical waxay ku guuleysatay dalabyo shan badeeco ah:Galka Kaadida ee La Laabi Karo oo Nuugaya, Qalabka Daadinta Fidinta Yar ee Duulaanka ah, Qalabka Kateetarka Fidinta Buufinta Kaadida,Dambiisha Soo Celinta Dhagaxa Endoscopic-ga, iyoTilmaamaha UrolojigaSi kastaba ha ahaatee, Well Lead Medical ma shaacin qiimaha gaarka ah ee lagu qiimeeyay.
Shaqaale ku takhasusay waaxda shaacinta macluumaadka ee Well Lead Medical ayaa yiri: "Marka la barbardhigo qiimayaashii hore ee isticmaaleyaasha, qiimaha wax iibsiga ee dhexe ayaa la filayaa inuu hoos u dhaco 60% ilaa 80%.
Qiimaha ugu badan ee la shaaciyay ee ku saabsan Hagaha Faragelinta Urolojiga wuxuu ahaa RMB 480; Sheyga Faragelinta Urolojiga (iyada oo aan lahayn shaqada cabbirka cadaadiska bayoolojiga ee goobta bartilmaameedka ah) wuxuu ahaa RMB 740; Sheyga Faragelinta Urolojiga (oo leh shaqada cabbirka cadaadiska bayoolojiga ee goobta bartilmaameedka ah) wuxuu ahaa RMB 1,030; Kateetarka Fidinta Buufinta Ureteriga wuxuu ahaa RMB 1,860; Dambiisha Soo Celinta Dhagaxa Urolojiga wuxuu ahaa RMB 800.
Sida laga soo xigtay hordhacii hore ee Well Lead Medical, faa'iidada guud ee guud ee khadka wax soo saarka qalliinka kaadimareenka ayaa ka badan 70%. Iyada oo suuqgeynta suuqa lagu sameeyay badeecadeeda ugu caansan,Galka Galitaanka Kaadida, sannadihii ugu dambeeyay, saameynta summada ee alaabada kaadimareenka ee Well Lead ayaa si tartiib tartiib ah uga muuqatay suuqa gudaha. Iyadoo ay weheliso saameynta beddelka soo dejinta, dakhliga iibka gudaha ee alaabada kaadimareenka ayaa gaaray kobac degdeg ah qeybtii hore ee sanadka.
Tan iyo 2023, shirkaddu waxay xoojisay dadaallada lagu ballaarinayo iibka dibadda ee alaabada kaadi-mareenka, iyadoo la aasaasayo koox xirfadlayaal ah oo loogu talagalay horumarinta ganacsiga caalamiga ah. Iyada oo loo marayo siminaaro iyo saloonno gaar ah oo loogu talagalay kor u qaadista badeecadaha saxda ah, natiijooyin muhiim ah ayaa la gaaray. Dakhliga iibka ee dibadda ee alaabada kaadi-mareenka ayaa sii waday koboc degdeg ah labadii sano ee la soo dhaafay.
Isla mar ahaantaana, iyadoo la hirgelinayo mashaariic loo habeeyey macaamiisha waaweyn ee dibadda, isku-darka badeecadaha ee ganacsiga dibadda ayaa si joogto ah loo hagaajiyaa. Saamiga badeecadaha sare ayaa sii kordhaya, taasoo kor u qaadaysa faa'iidada guud ee ganacsiga dibadda ee shirkadda. Waqtigan xaadirka ah, habka cilmi-baarista iyo horumarinta ee shirkaddu wuxuu diiradda saarayaa alaabada qiimaha sare leh ee lagu daray, kuwa sare leh. Iyada oo si joogto ah loo bilaabayo alaabada cusub, saamiga badeecadaha sare leh ayaa la filayaa inuu sii kordho mustaqbalka.
Marka laga hadlayo qaybinta awoodda wax soo saarka, awoodda wax soo saarka ugu weyn ee Well Lead Medical hadda waxay ku urursan tahay gudaha, iyadoo saldhigyada wax soo saarka ay ku yaalliin shan magaalo. Xarunta dhexe ee Guangzhou waxay leedahay laba goobood, oo inta badan soo saara suuxdin, qalliinka kaadi mareenka, kalkaalinta, iyo alaabada neefsashada. Goobta Haikou waxay inta badan soo saartaa alaabada kaadida; goobta Zhangjiagang waxay inta badan soo saartaa alaabada dhiig-baxa; goobta Suzhou waxay inta badan soo saartaa alaabada bamka xanuunka; goobta Ji'an, Jiangxi waxay inta badan soo saartaa alaabada andrology ee ku jirta khadka qalliinka kaadi mareenka.
Awoodda Wajiga I ee warshadaha dibadda waxay ugu horreyn siisaa macaamiisha Mareykanka. Shirkaddu waxay ku qiyaastay in kharashka wax soo saarka ee dhamaystiran ee warshadda Indonesia uu ka sarreyn doono kharashyada gudaha, kharashyada warshadda Mexico-na ay ka sii sarreyn doonaan, inkastoo xog gaar ah aan weli la xisaabin karin. Kharashka rarista iyo kaydinta alaabada warshadda Shiinaha laga dhoofiyo waxaa mas'uul ka ah macaamiisha. Haddii laga dhoofiyo warshadaha dibadda, kharashyada rarista iyo kaydinta macaamiisha ayaa la badbaadin doonaa, taasoo ka dhigaysa inay diyaar u yihiin inay aqbalaan heer sare oo koror qiimo ah oo loogu talagalay alaabada.
Mustaqbalka, shirkaddu waxay macaamiisha kala xaajoon doontaa qiimaha warshadihii hore ee alaabada ka imanaya warshadaha dibadda iyadoo lagu saleynayo kharashyada wax soo saarka dhabta ah ee goobahaas, iyadoo ujeedadu tahay in la ilaaliyo heerarka faa'iidada guud ee badeecada asalka ah. Waxaa la filayaa in wax soo saarka dibadda loo wareejiyo uusan si weyn u saameyn doonin faa'iidada guud ee badeecada.
Well Lead Medical waxay ku nuuxnuuxsanaysaa inay si joogto ah u wanaajinaysay awoodda wax soo saarka iyo kor u qaadidda otomaatiga wax soo saarka. Waqtigan xaadirka ah, heerarka isticmaalka awoodda ee dhammaan alaabada ayaa ku dhow inay buuxsamaan.
Intaa waxaa dheer, si wax looga qabto khataraha juqraafiyeed ee sii kordhaya ee dibadda, shirkaddu waxay dhisaysaa warshado dibadda ah oo ku yaal Indonesia iyo Mexico. Kuwaas waxaa ugu horreyn ku lug leh dhisidda khadadka wax soo saarka ee otomaatiga ah ee ganacsiga macaamiisha Waqooyiga iyo Koonfurta Ameerika. Marka la dhammeeyo labadan mashruuc, waxaa la filayaa in awoodda wax soo saarka shirkadda iyo heerarka otomaatiga ah si weyn loo horumariyo.
Annaga, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., waa shirkad soo saare ka ah Shiinaha oo ku takhasustay qalabka endoscopic-ga, oo ay ku jiraan khadka GI sida biopsy forceps, hemoclip, polyp snap, irbadda sclerotherapy, catheter buufin, burushyada cytology, hagewire, dambiisha soo celinta dhagaxa, catheter-ka dheecaanka biliary sanka iwm. kuwaas oo si weyn loogu isticmaalo EMR, ESD, ERCP. Iyo Urology Line, sidagalka marin u helidda kaadi mareenka oo leh nuugid, galka marin u helidda kaadi mareenka, la tuuri karoDambiisha Soo Celinta Dhagaxa Kaadida, iyo hagaha kaadi mareenka iwm.
Badeecadahayagu waa kuwa haysta shahaadada CE, warshadeenuna waa kuwo haysta shahaadada ISO. Badeecadahayagu waxaa loo dhoofiyay Yurub, Waqooyiga Ameerika, Bariga Dhexe iyo qayb ka mid ah Aasiya, waxayna si ballaaran u helaan macaamiisha aqoonsiga iyo ammaanta!
Waqtiga boostada: Jan-23-2026